Identification of Let-7f-5p as a novel biomarker of recurrence in non-muscle invasive bladder cancer
{{output}}
Background: Among patients diagnosed with non-muscle invasive bladder cancer (NMIBC), 30% to 70% experience recurrences within 6 to 12 years of diagnosis. The need to screen for these events every 3 to 6 months and ultimately ann... ...
